DE69816467D1 - Robo: eine familie polypeptiden und nukleinesäuren wirksam in nervenzellleitung - Google Patents

Robo: eine familie polypeptiden und nukleinesäuren wirksam in nervenzellleitung

Info

Publication number
DE69816467D1
DE69816467D1 DE69816467T DE69816467T DE69816467D1 DE 69816467 D1 DE69816467 D1 DE 69816467D1 DE 69816467 T DE69816467 T DE 69816467T DE 69816467 T DE69816467 T DE 69816467T DE 69816467 D1 DE69816467 D1 DE 69816467D1
Authority
DE
Germany
Prior art keywords
robo
polypeptides
nucleic acids
nervous
family
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69816467T
Other languages
English (en)
Other versions
DE69816467T2 (de
Inventor
S Goodman
Thomas Kidd
J Mitchell
Guy Tear
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California filed Critical University of California
Publication of DE69816467D1 publication Critical patent/DE69816467D1/de
Application granted granted Critical
Publication of DE69816467T2 publication Critical patent/DE69816467T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69816467T 1997-10-20 1998-10-20 Robo: eine familie polypeptiden und nukleinesäuren wirksam in nervenzellleitung Expired - Lifetime DE69816467T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US6292197P 1997-10-20 1997-10-20
US62921P 1997-10-20
US97117297A 1997-11-14 1997-11-14
US971172 1997-11-14
PCT/US1998/022164 WO1999020764A1 (en) 1997-10-20 1998-10-20 Robo: a family of polypeptides and nucleic acids involved in nerve guidance

Publications (2)

Publication Number Publication Date
DE69816467D1 true DE69816467D1 (de) 2003-08-21
DE69816467T2 DE69816467T2 (de) 2004-04-15

Family

ID=26742861

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69816467T Expired - Lifetime DE69816467T2 (de) 1997-10-20 1998-10-20 Robo: eine familie polypeptiden und nukleinesäuren wirksam in nervenzellleitung

Country Status (8)

Country Link
US (2) US20050059040A1 (de)
EP (1) EP1025231B1 (de)
JP (2) JP2003517262A (de)
AT (1) ATE245190T1 (de)
AU (1) AU729496B2 (de)
CA (1) CA2304926C (de)
DE (1) DE69816467T2 (de)
WO (1) WO1999020764A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1586660A1 (de) * 1997-04-18 2005-10-19 Millennium Pharmaceuticals, Inc. Neue Moleküle der T85-verwandten Proteinfamilie und ihre Verwendung
US7034132B2 (en) 2001-06-04 2006-04-25 Anderson David W Therapeutic polypeptides, nucleic acids encoding same, and methods of use
JP2005504307A (ja) * 2001-10-02 2005-02-10 メディカル リサーチ カウンシル 癌の早期検出のための方法
AU2002329438A1 (en) * 2001-10-02 2003-04-14 Medical Research Council Methods and animal models for tumor formation involving dutti
WO2003075860A2 (en) * 2002-03-08 2003-09-18 Abgent, Inc. Detection and modulation of slit and roundabount (robo) mediated angiogenesis and uses thereof
JP4643450B2 (ja) 2003-08-08 2011-03-02 株式会社ペルセウスプロテオミクス 癌高発現遺伝子
US8940488B2 (en) 2004-03-31 2015-01-27 Hiroyuki Aburatani Cancer diagnosis and treatment of cancer using anti-robo 1 antibody
DE602005022693D1 (de) 2004-03-31 2010-09-16 Perseus Proteomics Inc Krebsdiagnose und behandlung unter verwendung eines anti-robo1-antikörpers
JP5117765B2 (ja) 2007-05-28 2013-01-16 国立大学法人 東京大学 抗robo1抗体を含むpet用腫瘍診断剤
FR2958936A1 (fr) * 2010-04-14 2011-10-21 Sanofi Aventis Proteine de fusion robo1-fc et son utilisation dans le traitement des tumeurs
FR2969617A1 (fr) * 2010-12-23 2012-06-29 Sanofi Aventis Proteine de fusion robo1-fc et son utilisation dans le traitement des tumeurs.
US20130273049A1 (en) * 2010-12-23 2013-10-17 Sanofi Robo1-fc fusion protein for use in the treatment of hepatocarcinoma
PL2800578T3 (pl) * 2012-01-05 2019-05-31 Boston Medical Center Corp Przekazywanie sygnału przez Slit-Robo do diagnostyki i leczenia choroby nerek
AU2018278809B2 (en) 2017-06-02 2022-03-31 Boston Medical Center Corporation Recombinant ROBO2 proteins, compositions, methods and uses thereof
US11406682B2 (en) 2017-08-24 2022-08-09 Bar-Ilan University Roundabout (Robo) receptor inhibitors and uses thereof
US20220348628A1 (en) * 2019-09-24 2022-11-03 The Regents Of The University Of California Novel receptors having a fibronectin repeat for ligand-dependent transcriptional regulation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5565331A (en) * 1993-11-12 1996-10-15 The Regents Of The University Of California Nucleic acids encoding neural axon outgrowth modulators
EP1009856A4 (de) * 1997-04-18 2003-02-12 Millennium Pharm Inc Moleküle einer mit fthma-070 verwandten proteinfamilie und die mit t85 verwandte proteinfamilie und ihre verwendung

Also Published As

Publication number Publication date
AU1105799A (en) 1999-05-10
JP4636413B2 (ja) 2011-02-23
ATE245190T1 (de) 2003-08-15
US20100233819A1 (en) 2010-09-16
JP2003517262A (ja) 2003-05-27
US20050059040A1 (en) 2005-03-17
CA2304926A1 (en) 1999-04-29
AU729496B2 (en) 2001-02-01
CA2304926C (en) 2005-06-21
DE69816467T2 (de) 2004-04-15
EP1025231A1 (de) 2000-08-09
EP1025231B1 (de) 2003-07-16
WO1999020764A1 (en) 1999-04-29
JP2006174839A (ja) 2006-07-06

Similar Documents

Publication Publication Date Title
EP1005540A4 (de) Ikk-beta proteines, nukleinsäuren und verfahren
CA2295999A1 (en) Nik proteins, nucleic acids and methods
DE69816467D1 (de) Robo: eine familie polypeptiden und nukleinesäuren wirksam in nervenzellleitung
WO1998020165A3 (en) Biallelic markers
WO2001012659A3 (en) Human dna sequences
DE69808743D1 (en) Netrinrezeptoren
WO2000044928A3 (en) Materials and methods for the purification of polyelectrolytes
HU9601448D0 (en) Novel apoptosis-modulating proteins, dna encoding the proteins and methods of use thereof
CA2281895A1 (en) Ikb kinases
CA2294566A1 (en) Ikk-.alpha. proteins, nucleic acids and methods
WO1998006841A3 (en) Two human nsp-like proteins
CA2294476A1 (en) Semaphorin receptors
WO2000029623A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
TR199900277T2 (xx) Nematodlara ve/veya yaprak bitlerine kar�� diren�.
WO2003054167A3 (en) Identification of novel polymorphic sites in the human mglur8 gene and uses thereof
CA2273855A1 (en) Novel feline fc epsilon receptor alpha chain nucleic acid molecules, proteins and uses thereof
DE69939379D1 (de) Hemmstoff zur diagnose und behandlung von haemophilia a patienten
WO2000055193A3 (en) Human dan/cerberus related protein 6 (dcr6)
WO2001048245A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
WO1999053095A3 (en) Biallelic markers
WO2002072632A3 (en) Nucleic acids of the human abcc11 gene, vectors containing such nucleic acids and uses thereof.
WO2001036478A3 (en) Methods and compositions relating to bactericidal/permeability increasing factor-like polypeptides and polynucleotides
WO2002086067A3 (en) Mycobacterial sulfation pathway proteins and methods of use thereof
WO2000029622A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
WO2002036770A3 (fr) Sequences polymorphes du gene humain abca1, leurs utilisations, les methodes et kits de detection

Legal Events

Date Code Title Description
8364 No opposition during term of opposition